TrialRespiration; international review of thoracic diseases

Safety and Dose Study of Targeted Lung Denervation in Moderate/Severe COPD Patients.

Arschang Valipour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.